Shanghai Yeasen Biotechnology Co.,Ltd. – Trademark Portfolio
Entity Type: 03
Shanghai Yeasen Biotechnology Co.,Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include YEASEN. The owner is based in Shanghai.
Rm. 402,Bldg. 1
No. 166 Tianxiong Rd.,Pudong New Dist.
Shanghai 200120 , CN
Showing of trademarks Trademarks
Trademark Classifications
Shanghai Yeasen Biotechnology Co.,Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Shanghai Yeasen Biotechnology Co.,Ltd. have?
Shanghai Yeasen Biotechnology Co.,Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Shanghai Yeasen Biotechnology Co.,Ltd. file in?
Shanghai Yeasen Biotechnology Co.,Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Shanghai Yeasen Biotechnology Co.,Ltd.'s most well-known trademarks?
Shanghai Yeasen Biotechnology Co.,Ltd.'s registered trademark portfolio includes well-known marks such as YEASEN. These are among 2 currently registered trademarks in the portfolio.
What is Shanghai Yeasen Biotechnology Co.,Ltd.'s trademark registration success rate?
Shanghai Yeasen Biotechnology Co.,Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.